- What are the top holdings of LFSC?
- F/M Emerald Life Sciences Innovation ETF holds — securities in total. The largest positions and their portfolio weights are listed on the Holdings tab.
- How many holdings does LFSC have?
- LFSC holds — positions as reported by the fund's most recent disclosure.
- What sectors does LFSC invest in?
- F/M Emerald Life Sciences Innovation ETF (LFSC) allocates across the sectors shown above. The largest exposure tops the list; the rest follow in descending weight order.
- What sector is LFSC most exposed to?
- LFSC's full sector breakdown is on the Sectors tab. The largest sector weight is shown there along with the rest of the allocation.
- Is LFSC a US-only fund?
- The country allocation card on this page shows LFSC's geographic exposure. Funds with > 95% US weight are effectively US-only; international or global funds will show meaningful weights across multiple countries.
- What does LFSC invest in?
- LFSC seeks to invest in innovative life sciences companies that are expected to create value and long-term growth. The actively managed fund relies on a specialized and experienced team to research complex life sciences companies. It invests in US equity securities identified to have growth potential that meet the criteria of technological advancement, market disruption, or artificial intelligence. The broad life science field includes biotechnology, pharmaceutical, medical diagnostics and devices, healthcare services and technologies, and synthetic biology. Stock selection employs an extensive 10-step research process that includes reviews of publicly available and third-party information, peer reviews, financial and valuation models, internal research, surveys, as well as interviews and contact with management, industry and medical professionals, supply chain, and collaboration within the investment team. The fund may invest up to 20% in foreign companies listed on a US exchange.
